Achiever's Success Story
“Democratizing Healthcare to go beyond Diagnostics"
Mr Mahesh Galgalikar is an entrepreneur and innovator across a broad technology landscape including MEMS sensors, BioSensing, IoT, Cloud Technology, manufacturing, AI in Healthcare and Fitness consumer products. He is a distinguished Scientist and is the youngest Indian to be recognised by the United States of America with the prestigious “Einstein Visa” which is also known as EB1A- Alien of Extraordinary ability at the age of 29, to share such a category with the greats like Nobel Laureate Physicist Albert Einstein hence known as “Einstein Visa”. The US Government maintains a tradition of awarding such prestigious honors to people who have significant impact on the world with their work and original scientific contributions.
Mr. Galgalikar is the Founder and CEO of KardioGenics, Inc USA and Misceo Innovative Health Solution Pvt. Ltd, India. Company has pioneered a unique biosensing platform to understand complicated human cardiac conditioning and its response to various scenarios. It’s a unique tele-medicine platform which focuses on co-relating electrophysiological and hemodynamic parameters to understand patients’ response to various therapeutic drugs and treatments. A technology not only capable of improving accessibility of healthcare services in remote areas but also optimizing the quality of care and treatment outcomes. His work has garnered many accolades. Company was recognized as the “10 Most Innovative Medical Device Company, 2018 by InsightsSuccess, and was featured at American college of Cardiology 68th Scientific Session & Expo 2019 as a Company driving the Future of Digital health. His work has been showcased in several media houses like Huffington Post, Democrats and Chronicles, Insights Success media and several well known blogs. Mr Galgalikar serves as a Global Panelist at MIT(Massachusetts Institute of Technology)Technology Review, a prestigious media company whose analysis, features, reviews, interviews focus on the commercial, social and political impact of new technologies and plays a crucial role in predicting global technology roadmap. He is also an Advisor to University of San Francisco Health Hub and MIT Covid 19 Challenge, a global initiative focused on the most pressing issues of the COVID–19 crisis.
Mr. Galgalikar has a humble background where he pursued Bachelors of Engineering from Amravati University. Post completion of his Bachelor’s degree he chose to pursue his Masters of Science in Microelectronics in the United States of America from Rochester Institute of Technology New York.
His passion for technology led him to conduct research in various fields like BioSensor Design, Microelectromechanical Systems, Microfluidics and Digital BioSignal Processing. He was the first Indian to receive a Distinguished Researcher Scholarship “Venkat Purushottam Award“ from the President of Kodak Corporation at Rochester Institute of Technology.
During his research tenure, he served as Designated Reviewer and Technical program committee at IEEE a prestigious professional association for electronic engineering and electrical engineering where he was responsible for ensuring a well-balanced, high-quality conference programs, paper submission, review and selection towards the establishment of the final conference program, a position which has high standing in academia.
His passion for the intersection of healthcare technology and medical field led him to pursue specialization in Inherited Cardiovascular Disease and Sports Cardiology from Stanford University. As a Subject Matter Expert, Mr. Galgalikar has served as Industrial advisor and Chair for various thesis committees for San Jose State University California and Rochester Institute of Technology where several post graduate students have graduated under his mentorship and guidance.